Simple Science

Cutting edge science explained simply

# Biology# Immunology

Impact of Autonomic Nervous System on Immune Health in HIV

Study explores how autonomic dysfunction affects immune responses in people living with HIV.

― 6 min read


ANS and Immune Health inANS and Immune Health inHIVresponse issues in HIV patients.Autonomic dysfunction linked to immune
Table of Contents

The autonomic nervous system (ANS) helps control many automatic body functions. It affects heart rate, breathing, and digestion, among other things. Recent studies show the ANS plays a vital role in how our immune system responds, especially in cases of inflammation. However, we still have a limited understanding of how the ANS and immune system work together, especially in humans.

Many years of research have shown that people living with HIV often experience a condition known as autonomic neuropathy (AN). This condition can lead to serious health problems and is common among these individuals. More recent findings have linked AN to other long-term Inflammatory conditions such as Long Covid, myalgic encephalomyelitis/chronic fatigue syndrome, and various autoimmune diseases. Even though AN is frequent in these conditions, the reasons behind this link remain unclear, and we need to learn more about how the ANS and immune system interact.

The Role of the ANS in Immune Response

Laboratory studies and animal research reveal that the ANS can influence immune responses through various pathways. The ANS consists of sympathetic and parasympathetic parts, which work together to manage immune signaling. Lymphoid organs, which play key roles in immune function, are heavily connected to the sympathetic nervous system. The chemical norepinephrine is released during sympathetic activity and can either stimulate or inhibit immune cells depending on the concentration.

On the other hand, the parasympathetic system, especially through the vagus nerve, has an anti-inflammatory role. Activation of this pathway can reduce inflammation in the body. For example, researchers have shown that a neurotransmitter called acetylcholine, released by the vagus nerve, can lower levels of pro-inflammatory substances in immune cells.

Despite the potential pathways through which the ANS regulates immune responses, our current knowledge mainly comes from studies that focus on the parasympathetic aspect. Observational research shows that lower activity of the vagus nerve is found in people with inflammatory conditions like inflammatory bowel disease and rheumatoid arthritis. There is evidence suggesting that stimulating the vagus nerve may lower inflammation in some diseases.

However, the sympathetic side of the ANS remains less explored in connection to immune responses, leaving us with a gap in knowledge of how this system impacts inflammation and immune function.

Study Goals

This study set out to achieve three main objectives:

  1. To look at the link between Interleukin-6 (IL-6), a pro-inflammatory substance, and the vagus nerve function in people with HIV.
  2. To examine how different types of autonomic dysfunction (whether sympathetic or parasympathetic) relate to various immune profiles using advanced statistical methods.
  3. To compare the health problems that arise from conditions unrelated to HIV among different immune profiles.

Understanding how the ANS impacts the immune system could lead to new treatment approaches to help people manage their symptoms better.

Study Overview

This research was designed as a cross-sectional observational study. Participants were recruited from a primary care clinic serving many people living with HIV. To qualify, participants had to be at least 18 years old, have a stable HIV condition, and have been on antiretroviral treatment for several months. Individuals with other conditions that may affect the ANS or those taking certain medications were excluded.

All the procedures were conducted according to ethical guidelines, and each participant gave written informed consent.

Testing the Autonomic Nervous System

To evaluate autonomic function, a set of non-invasive tests was performed. These tests measure sweat response, heart rate reactions, and blood pressure changes in response to specific maneuvers. These results help create a score reflecting overall ANS health.

The tests revealed that many participants had some degree of autonomic dysfunction. For instance, a significant number displayed issues with both sympathetic and parasympathetic functions.

Analyzing Medical History

Participants' medical histories were gathered to consider the impact of existing health conditions and medications on the study results. Several measures were used to control for the effects of these variables in the analysis. Additionally, participants completed questionnaires to assess their mental health and stress levels.

Collecting Blood Samples

Blood samples were taken to analyze various proteins related to inflammation. Using advanced technology, the research team measured levels of IL-6 and other inflammatory markers.

Advanced Cellular Analysis

For a detailed look at cellular differences, a high-tech method called CyTOF was used. This method allowed researchers to compare the immune cell types present in individuals with and without AN. Results showed that those with AN had a greater number of certain immune cells, specifically CD8+ T-cells, known for their role in fighting infections.

Findings on Demographics and Autonomic Function

The study included 79 participants, most of whom were middle-aged men. Many had been living with HIV for a long time. The results showed that a significant percentage experienced autonomic dysfunction. While most had mild issues, many participants had more severe problems affecting different areas of the ANS.

When examining the relationship between IL-6 and vagus nerve function, results indicated that individuals with lower vagal activity had greater IL-6 levels. This is concerning as elevated IL-6 is connected to worsening health outcomes.

Identifying Immune Profiles

The researchers identified four distinct immune profiles or “immunotypes” among the participants, each with unique patterns concerning inflammation and the presence of AN.

  • Immunotype 1 displayed high levels of pro-inflammatory markers, was older, and had a higher burden of health issues.
  • Immunotype 2 was younger with a decent inflammation profile but also showed signs of anti-inflammatory markers.
  • Immunotype 3 had a lower inflammatory profile and a different balance of immune cells.
  • Immunotype 4 did not show the same inflammatory tendencies as the first two but showed signs of immune cells better at signaling.

The Impact of Autonomic Dysfunction on Immune Function

The analysis revealed that people with AN were more likely to fall into Immunotype 1, characterized by significant inflammation and coexisting health issues. This relationship highlights the potential impact that autonomic dysfunction has on immune responses and inflammation levels.

Even within the inflammatory profiles, sympathetic nervous system issues emerged as a significant factor. Those classified under Immunotype 1 often had both sympathetic and parasympathetic issues, leading to complex interactions within the immune system.

Recap and Conclusion

This study emphasizes the important role of both the sympathetic and parasympathetic systems in regulating immune responses, particularly in those living with HIV. The evidence supports the idea that a poorly functioning ANS contributes to inflammation and overall health deterioration. Understanding these connections opens new avenues for research and potential treatments focused on improving ANS function.

The results can inform future studies exploring how aging interacts with immune function in the context of chronic conditions. A better grasp of how these systems relate could lead to strategies that help manage chronic inflammatory diseases more effectively, ultimately improving patient outcomes.

Original Source

Title: Autonomic and Immune Stress Response Networks in Patients Living With HIV

Abstract: Background and ObjectivesStress response systems are frequently dysregulated in patients with chronic inflammatory disorders. Pre-clinical studies have demonstrated direct influences of the sympathetic and vagal/parasympathetic branches of the autonomic nervous system (ANS) on the immune system. However, these connections have not been examined in humans. We hypothesized that the subtype and severity of autonomic neuropathy (AN) would predict immune phenotypes with distinct clinical and demographic characteristics in people living with HIV. MethodsThis is a cross-sectional study of 79 adult people with a history of well-controlled HIV on stable combination antiretroviral treatment (CART) recruited from a primary care clinic network within the Mount Sinai Health System in New York City. All participants underwent a standardized battery of autonomic function tests summarized as the Composite Autonomic Severity Score (CASS) and vagal and adrenergic baroreflex sensitivity (BRS-V and BRS-A). Immune profiling included: 1) measurement of interleukin-6 (IL-6) as part of the Olink assay Target 96 Inflammation Panel, 2) non-negative matrix factorization (NMF) clustering analyses on Olink immune biomarkers, and 3) mass cytometry (CyTOF) on a subset of participants with and without autonomic neuropathy (N = 10). ResultsReduced activity of caudal vagal circuitry involved in the cholinergic anti-inflammatory pathway (CAP) predicted higher levels of IL-6 (Spearmans rho = -0.352, p=0.002). The comprehensive assessment of the ANS-immune network showed four immunotypes defined by NMF analyses. A pro-inflammatory immunotype defined by elevations in type 1 cytokines (IL-6, IL-17) and increased numbers of CD8+ T-cells was associated with autonomic neuropathy (AN). This association was driven by deficits in the cardiovascular sympathetic nervous system and remained strongly significant after controlling for the older age and greater burden of co-morbid illness among participants with this immunotype (aOR=4.7, p=0.017). DiscussionOur results provide novel support for the clinical relevance of the CAP in patients with chronic inflammatory AN. These data also provide insight regarding the role of the sympathetic nervous system and aging in the progression and development of co-morbidities in patients with chronic HIV and support future research aimed at developing therapies focused on modulation of the sympathetic and parasympathetic/vagal nervous system.

Authors: Bridget R Mueller, M. Mehta, M. Campbell, N. Neupane, G. Cedillo, G. Lee, K. Coyle, J. Qi, Z. Chen, M. C. George, J. Robinson-Papp

Last Update: 2024-11-04 00:00:00

Language: English

Source URL: https://www.biorxiv.org/content/10.1101/2024.10.15.618447

Source PDF: https://www.biorxiv.org/content/10.1101/2024.10.15.618447.full.pdf

Licence: https://creativecommons.org/licenses/by/4.0/

Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.

Thank you to biorxiv for use of its open access interoperability.

More from authors

Similar Articles